Reader Comments
Post a new comment on this article
Post Your Discussion Comment
Please follow our guidelines for comments and review our competing interests policy. Comments that do not conform to our guidelines will be promptly removed and the user account disabled. The following must be avoided:
- Remarks that could be interpreted as allegations of misconduct
- Unsupported assertions or statements
- Inflammatory or insulting language
Thank You!
Thank you for taking the time to flag this posting; we review flagged postings on a regular basis.
closeMedia Coverage of This Article
Posted by PLOS_ONE_Group on 03 May 2013 at 20:45 GMT
The following article represents some of the media coverage that has occurred for this paper:
Publication: Pipeline Review
Title: “Clinical Results for Oramed's Oral Diabetes Treatment Published in Peer Reviewed Journal PLOS ONE”
http://www.pipelinereview...
Publication: Street Insider
Title: “StreetInsider.com - Oramed Pharma (ORMP) Announces Publication of ORMD-0801 Data in PLOS ONE”
http://www.streetinsider....(ORMP)+Announces+Publication+of+ORMD-0801+Data+in+PLOS+ONE/8292631.html
Publication: Sys Con Media
Title: “Clinical Results for Oramed's Oral Diabetes Treatment Published in Peer Reviewed Journal PLOS ONE”
http://www.sys-con.com/no...
Publication: Market Watch
Title: “Clinical Results for Oramed's Oral Diabetes Treatment Published in Peer Reviewed Journal PLOS ONE”
http://www.marketwatch.co...
If you see any additional coverage of this paper in the press or blogosphere, please reply to this thread and add the link to the article.
RE: Media Coverage of This Article
PLOS_ONE_Group replied to PLOS_ONE_Group on 13 May 2013 at 16:07 GMT
The following article represents some of the media coverage that has occurred for this paper:
Publication: PR-Newswire
Title: “Clinical Results for Oramed's Oral Diabetes Treatment Published in Peer Reviewed Journal PLOS...”
http://www.prnewswire.com...
If you see any additional coverage of this paper in the press or blogosphere, please reply to this thread and add the link to the article.
Media Coverage of This Article
PLOS_ONE_Group replied to PLOS_ONE_Group on 23 Aug 2013 at 17:47 GMT
The following article represents some of the media coverage that has occurred for this paper:
Publication: Market Watch
Title: “Oramed Initiates Patient Recruitment for a New Clinical Trial in Israel of its Oral Insulin Drug ORMD-0801 in the Treatment of Type 1 Diabetes”
http://www.marketwatch.co...
Publication: PR Newswire press release
Title: “Oramed Initiates Patient Recruitment for a New Clinical Trial in Israel of its”
http://www.prnewswire.com...
If you see any additional coverage of this paper in the press or blogosphere, please reply to this thread and add the link to the article.
Media Coverage of This Article
PLOS_ONE_Group replied to PLOS_ONE_Group on 03 Sep 2013 at 23:01 GMT
The following article represents some of the media coverage that has occurred for this paper:
Publication: PR Newswire press release
Title: “Oramed Initiates Patient Recruitment for a New Clinical Trial in Israel of its... -- JERUSALEM, August 21, 2013 /PRNewswire/ --”
http://www.prnewswire.com...
If you see any additional coverage of this paper in the press or blogosphere, please reply to this thread and add the link to the article.
Media Coverage of This Article
PLOS_ONE_Group replied to PLOS_ONE_Group on 17 Sep 2013 at 15:59 GMT
The following articles represent some of the media coverage that has occurred for this paper:
Publication: Life Science Online
Title: “Oramed Pharmaceuticals Inc. (ORMP.OB) Initiates Patient Recruitment for a New Clinical Trial in Israel of its Oral Insulin Drug ORMD-0801 in the Treatment of Type 1 Diabetes”
http://www.lifescience-on...
If you see any additional coverage of this paper in the press or blogosphere, please reply to this thread and add the link to the article.